eTherapeutics Company
eTherapeutics focuses on the discovery of cancer and degenerative diseases of the nervous system.
Total Funding:
112043919.0
Acquisitions Number:
1
Headquarters:
Hanborough, Oxfordshire, United Kingdom
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
Post-IPO Equity
Technology:
Biotechnology, Health Care, Medical
Investor Type:
Company
Last Funding Date:
2022-09-30
Investors Number:
2.0
Founded Date:
2003-01-01
Industry:
Early Drug Development